Causes of early mortality in pediatric trauma patients

Christina M Theodorou1, Laura A Galganski, Gregory J Jurkovich

  • 1From the Department of Surgery, Division of Pediatric General, Thoracic, and Fetal Surgery (C.M.T., L.A.G., D.L.F., S.H., J.T.S.); Department of Surgery, Division of Trauma, Acute Care, and General Surgery (G.J.J.), University of California Davis Medical Center, Sacramento, California; Department of Surgery (J.T.S.), Uniformed Services University of the Health Sciences, Bethesda, Maryland; and Department of Pediatric Surgery, University of Texas Health Science Center at Houston (A.F.T.), Houston, Texas.

Insights

Half of pediatric trauma deaths occur within 24 hours, with traumatic brain injury being the leading cause. Early intervention for hemorrhage control is critical, especially for gunshot wounds in adolescents.

Area of Science:

  • Pediatric Trauma Care
  • Injury Epidemiology
  • Emergency Medicine

Background:

  • Trauma is the leading cause of death in children.
  • Most pediatric trauma deaths occur within 24 hours of injury.
  • Understanding immediate causes of death is crucial for improving survival rates.

Purpose of the Study:

  • To analyze the causes and timing of death in pediatric trauma patients.
  • To identify specific injury patterns associated with early mortality.
  • To inform strategies for preventing deaths in the critical early period after trauma.

Main Methods:

  • Retrospective review of pediatric trauma admissions (ages 0-17) from 2009-2019.
  • Stratification of patients by age groups (0-6, 7-12, 13-17).
  • Analysis of cause of death, with a focus on early deaths (within 24 hours).

Main Results:

  • 134 deaths (2%) occurred, with a median age of 7 years.
  • Traumatic brain injury was the most common cause of death (66%).
  • Hemorrhage accounted for 8% of deaths, predominantly in adolescents with gunshot wounds, all occurring within 6 hours.

Conclusions:

  • Half of pediatric trauma deaths occur within 24 hours.
  • Hemorrhage is a rare but rapidly fatal cause of death, necessitating immediate intervention.
  • Development of novel hemorrhage control adjuncts for children is urgently needed.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
128
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
106
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
365
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
762